 |
Iodine I-131 radiolabeled chimeric MAb tumor necrosis treatment (TNT-1B) |
|---|---|
| Trade Name | 131ichtnt-1 |
| Orphan Indication | Glioblastoma |
| USA Market Approval | USA |
| USA Designation Date | 1999-02-12 00:00:00 |
| Sponsor | Peregrine Pharmaceuticals, Inc.;14282 Franklin Ave.;Tustin, California, 92780 |
